Literature DB >> 1724244

Endothelial cell regulation by transforming growth factor-beta.

A RayChaudhury1, P A D'Amore.   

Abstract

Pronounced changes including growth inhibition, increased matrix deposition and suppression of cell-associated proteolytic activity, take place in endothelial cells (EC) upon the application of TGF-beta. Interrelationships between these effects have shed some light on the mechanism of action of TGF-beta and on its role in regulating EC function vis-a-vis angiogenesis. For instance, preliminary evidence has indicated that increased levels of certain matrix components may be partly responsible for the antiproliferative action of TGF-beta. In addition, TGF-beta and bFGF have opposing effects on cellular proteolytic balance which may contribute to the antagonistic effect that TGF-beta has on bFGF-induced EC growth and possibly to the anti-angiogenic effect exerted by TGF-beta under certain circumstances. Of particular interest in this regard is the fact that physical contact between EC and vascular mural cells in EC:mural cell cocultures has been found to generate active TGF-beta, thus further implicating TGF-beta in the maintenance of the quiescent, differentiated aggregation of EC as found in vascular structures in vivo. While more information is needed to define what, if any role TGF-beta plays in endothelial differentiation, it is to be noted that many of the cellular and biochemical processes affected by TGF-beta are linked to differentiation. It is therefore possible that the growth inhibition of EC by TGF-beta primes them for differentiation and/or is critical for the maintenance of a differentiated state.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1724244     DOI: 10.1002/jcb.240470307

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  16 in total

1.  Bilateral osteonecrosis of the tarsus coincident with glioblastoma multiforme.

Authors:  M Heliotis; E Tsiridis; S T Donell; T J Marshall; D G Scott
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

2.  Reactive oxygen species production via NADPH oxidase mediates TGF-beta-induced cytoskeletal alterations in endothelial cells.

Authors:  Taishan Hu; Satish P Ramachandrarao; Senthuran Siva; Cathryn Valancius; Yanqing Zhu; Kalyankar Mahadev; Irene Toh; Barry J Goldstein; Marilyn Woolkalis; Kumar Sharma
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

Review 3.  Signal transduction in vasculogenesis and developmental angiogenesis.

Authors:  Sunita Patel-Hett; Patricia A D'Amore
Journal:  Int J Dev Biol       Date:  2011       Impact factor: 2.203

Review 4.  Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs.

Authors:  I F Dunn; O Heese; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

5.  Pericyte contractility controls endothelial cell cycle progression and sprouting: insights into angiogenic switch mechanics.

Authors:  Jennifer T Durham; Howard K Surks; Brian M Dulmovits; Ira M Herman
Journal:  Am J Physiol Cell Physiol       Date:  2014-08-20       Impact factor: 4.249

Review 6.  Microvascular modifications in diabetic retinopathy.

Authors:  Jennifer T Durham; Ira M Herman
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

7.  Role of transforming growth factor-[beta]1 in inhibiting endothelial cell proliferation in experimental alcoholic liver disease.

Authors:  A A Nanji; S R Tahan; M Golding; S Khwaja; A Rahemtulla; E N Lalani
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

8.  Cell-cell signaling between adult rat ventricular myocytes and cardiac microvascular endothelial cells in heterotypic primary culture.

Authors:  M Nishida; J P Springhorn; R A Kelly; T W Smith
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Normoxic wound fluid contains high levels of vascular endothelial growth factor.

Authors:  T R Howdieshell; C Riegner; V Gupta; D Callaway; K Grembowicz; P L McNeil
Journal:  Ann Surg       Date:  1998-11       Impact factor: 12.969

10.  Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.

Authors:  N Pece; S Vera; U Cymerman; R I White; J L Wrana; M Letarte
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.